Invizius
Invizius is a biotech company developing breakthrough treatments for dialysis patients. Its H-Guard product addresses inflammatory responses during dialysis, potentially preventing life-threatening complications. A 'First in Human' study demonstrated safety and tolerability, paving the way for further clinical trials.
Buy Funded Startups lists
Funding Round:
Funding Amount: £950K
Date: 24-Sep-2024
Investors: Mercia Ventures, Calculus Capital, Syensqo, University of Edinburgh's Old College Capital, Scottish Enterprise
Markets: Biotech, Healthtech, Pharmaceutical Manufacturing, Therapeutic Devices, Other Devices and Supplies
HQ: Motherwell, North Lanarkshire, Scotland, United Kingdom
Founded: 2018
Website: https://www.invizius.com/
LinkedIn: https://www.linkedin.com/company/invizius-limited
Twitter: https://twitter.com/inviziusmed
Leave a Comment
Comments
No comments yet.